# Evaluation of Drug Interaction Between HS-10234 and Emtriccitabine

> **NCT04477096** · PHASE1 · COMPLETED · sponsor: **Jiangsu Hansoh Pharmaceutical Co., Ltd.** · enrollment: 36 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** HS-10234
- **DRUG:** Emtricitabine

## Key facts

- **NCT ID:** NCT04477096
- **Lead sponsor:** Jiangsu Hansoh Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-03
- **Primary completion:** 2020-09-24
- **Final completion:** 2020-09-24
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2020-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04477096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04477096, "Evaluation of Drug Interaction Between HS-10234 and Emtriccitabine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04477096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*